OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1752-1752
Open Access | Times Cited: 37
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1752-1752
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 79
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 79
Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 24
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 24
Navigating the dementia landscape: Biomarkers and emerging therapies
Shubhrat Maheshwari, Aditya Singh, Valeed Ahmad Ansari, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102193-102193
Closed Access | Times Cited: 14
Shubhrat Maheshwari, Aditya Singh, Valeed Ahmad Ansari, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102193-102193
Closed Access | Times Cited: 14
Neuromodulation by nanozymes and ultrasound during Alzheimer’s disease management
Viswanathan Karthika, Badrinathan Sridharan, Ji Won Nam, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Viswanathan Karthika, Badrinathan Sridharan, Ji Won Nam, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Neuroinflammation: A Critical Factor in Neurodegenerative Disorders
Zahieh Suleiman Khoury, Fatima Sohail, Jada Wang, et al.
Cureus (2024)
Open Access | Times Cited: 7
Zahieh Suleiman Khoury, Fatima Sohail, Jada Wang, et al.
Cureus (2024)
Open Access | Times Cited: 7
Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers
Mohammad Azam Ansari, Takshashila Tripathi, Baskar Venkidasamy, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 3042-3089
Closed Access | Times Cited: 14
Mohammad Azam Ansari, Takshashila Tripathi, Baskar Venkidasamy, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 3042-3089
Closed Access | Times Cited: 14
Designing and Formulation of Nanocarriers for “Alzheimer’s and Parkinson’s” Early Detection and Therapy
Jakleen Abujamai, Rukhsana Satar, Shakeel Ahmed Ansari
CNS & Neurological Disorders - Drug Targets (2024) Vol. 23, Iss. 10, pp. 1251-1262
Closed Access | Times Cited: 5
Jakleen Abujamai, Rukhsana Satar, Shakeel Ahmed Ansari
CNS & Neurological Disorders - Drug Targets (2024) Vol. 23, Iss. 10, pp. 1251-1262
Closed Access | Times Cited: 5
Non-Drug and Non-Invasive Therapeutic Options in Alzheimer’s Disease
Alina Simona Șovrea, Adina Bianca Boşca, Eleonora Dronca, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 84-84
Open Access
Alina Simona Șovrea, Adina Bianca Boşca, Eleonora Dronca, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 84-84
Open Access
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access
Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies
Jurga Bernatonienė, Mindaugas Plieskis, Kęstutis Petrikonis
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 352-352
Open Access
Jurga Bernatonienė, Mindaugas Plieskis, Kęstutis Petrikonis
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 352-352
Open Access
Nanomedicine: a cost-effective and powerful platform for managing neurodegenerative diseases
Majid Hassanzadeh-khanmiri, Amirreza Moshari, Reza Kheradmand, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Majid Hassanzadeh-khanmiri, Amirreza Moshari, Reza Kheradmand, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Nanobilosome as custom-tailored modality in addressing Alzheimer’s disease: advancements and translational glitches
Biswabhusan Biswal, Bhabani Sankar Satapathy, Laxmidhar Maharana, et al.
Journal of Dispersion Science and Technology (2025), pp. 1-32
Closed Access
Biswabhusan Biswal, Bhabani Sankar Satapathy, Laxmidhar Maharana, et al.
Journal of Dispersion Science and Technology (2025), pp. 1-32
Closed Access
Breaking the barriers in management of Alzheimer's disease through cationic nanoformulation: A review
Abhijeet Puri, Popat Mohite, Showkhiya Khan, et al.
Results in Chemistry (2024) Vol. 7, pp. 101463-101463
Open Access | Times Cited: 4
Abhijeet Puri, Popat Mohite, Showkhiya Khan, et al.
Results in Chemistry (2024) Vol. 7, pp. 101463-101463
Open Access | Times Cited: 4
Chemistry, Biological Activities, and Pharmacological Properties of Gastrodin: Mechanism Insights
Naoual El Menyiy, Youssef Elouafy, Rania Moubachir, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 4
Naoual El Menyiy, Youssef Elouafy, Rania Moubachir, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 4
Evolution of lipid nanoparticles as charioteers of Alzheimer's disease therapeutics
Brati Chakraborty, Gayatri Patel, Bandana Padhan, et al.
Applied Materials Today (2024) Vol. 41, pp. 102442-102442
Closed Access | Times Cited: 4
Brati Chakraborty, Gayatri Patel, Bandana Padhan, et al.
Applied Materials Today (2024) Vol. 41, pp. 102442-102442
Closed Access | Times Cited: 4
Nexus of NFκB/VEGF/MMP9 signaling in diabetic retinopathy-linked dementia: Management by phenolic acid-enabled nanotherapeutics
Vikrant Singh, Siva Prasad Panda
Life Sciences (2024), pp. 123123-123123
Closed Access | Times Cited: 2
Vikrant Singh, Siva Prasad Panda
Life Sciences (2024), pp. 123123-123123
Closed Access | Times Cited: 2
Nanomedicine and drug delivery: A comprehensive review of applications and challenges
Kalpana Singh, Sanjeev Singhal, Shilpa Pahwa, et al.
Nano-Structures & Nano-Objects (2024) Vol. 40, pp. 101403-101403
Closed Access | Times Cited: 2
Kalpana Singh, Sanjeev Singhal, Shilpa Pahwa, et al.
Nano-Structures & Nano-Objects (2024) Vol. 40, pp. 101403-101403
Closed Access | Times Cited: 2
Nanozymes in Alzheimer's disease diagnostics and therapy
Linquan Li, Wenyu Zhang, Hengyi Cao, et al.
Biomaterials Science (2024) Vol. 12, Iss. 18, pp. 4519-4545
Closed Access | Times Cited: 1
Linquan Li, Wenyu Zhang, Hengyi Cao, et al.
Biomaterials Science (2024) Vol. 12, Iss. 18, pp. 4519-4545
Closed Access | Times Cited: 1
Nanotechnological advancement for the treatment of neurodegenerative disorders
Garima Rai, Surbhi Sharma, Aditi Singh, et al.
Journal of Dispersion Science and Technology (2024), pp. 1-19
Closed Access | Times Cited: 1
Garima Rai, Surbhi Sharma, Aditi Singh, et al.
Journal of Dispersion Science and Technology (2024), pp. 1-19
Closed Access | Times Cited: 1
A critical review on the role of nanotheranostics mediated approaches for targeting β amyloid in Alzheimer’s
Vaibhav Rastogi, Anjali Jain, Prashant Kumar, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 7, pp. 725-744
Closed Access | Times Cited: 4
Vaibhav Rastogi, Anjali Jain, Prashant Kumar, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 7, pp. 725-744
Closed Access | Times Cited: 4
Nanopharmacology as a new approach to treat neuroinflammatory disorders
Sebastián García Menéndez, Walter Manucha
Translational Neuroscience (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Sebastián García Menéndez, Walter Manucha
Translational Neuroscience (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Alzheimer’s disease and clinical trials
Deepraj Paul, Rohini Agrawal, Swati Singh
Journal of Basic and Clinical Physiology and Pharmacology (2024) Vol. 35, Iss. 1-2, pp. 31-44
Closed Access | Times Cited: 1
Deepraj Paul, Rohini Agrawal, Swati Singh
Journal of Basic and Clinical Physiology and Pharmacology (2024) Vol. 35, Iss. 1-2, pp. 31-44
Closed Access | Times Cited: 1
The Role of Artificial Intelligence and Machine Learning in Accelerating the Discovery and Development of Nanomedicine
Vivek Agrahari, Yahya E. Choonara, Mitra Mosharraf, et al.
Pharmaceutical Research (2024)
Closed Access | Times Cited: 1
Vivek Agrahari, Yahya E. Choonara, Mitra Mosharraf, et al.
Pharmaceutical Research (2024)
Closed Access | Times Cited: 1
Role of nanotechnology in therapeutics and diagnosis of Alzheimer’s disease
Dhivya P. Sundaram, Swathy Govindaswamy, S. Mathiazhagan, et al.
Neuroscience Research Notes (2024) Vol. 7, Iss. 1
Open Access
Dhivya P. Sundaram, Swathy Govindaswamy, S. Mathiazhagan, et al.
Neuroscience Research Notes (2024) Vol. 7, Iss. 1
Open Access
Review on Study of Nanoparticles in Brain Targeting for Treatment Of Alzheimer’s
G T Mamatha, Satish Pavuluri
Journal of Drug Delivery and Therapeutics (2024) Vol. 14, Iss. 6, pp. 251-261
Open Access
G T Mamatha, Satish Pavuluri
Journal of Drug Delivery and Therapeutics (2024) Vol. 14, Iss. 6, pp. 251-261
Open Access
